COGNIS FRANCE S.A. – Trademark Portfolio

Entity Type: 03

COGNIS FRANCE S.A. holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 14 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include ASEBIOL, INDINYL, DULCEMIN, OSMHYDRAN, and PROTEASYL. The owner is based in SAINT MARTORY.

BOUSSENS

SAINT MARTORY 31360 , FR

20 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

COGNIS FRANCE S.A.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (14 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

1
Chemicals (12 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does COGNIS FRANCE S.A. have?

COGNIS FRANCE S.A. has 20 U.S. trademarks filed with the USPTO. Of these, 8 registered, 12 cancelled.

What trademark classes does COGNIS FRANCE S.A. file in?

COGNIS FRANCE S.A. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are COGNIS FRANCE S.A.'s most well-known trademarks?

COGNIS FRANCE S.A.'s registered trademark portfolio includes well-known marks such as ASEBIOL, INDINYL, DULCEMIN, OSMHYDRAN, and PROTEASYL. These are among 8 currently registered trademarks in the portfolio.

What is COGNIS FRANCE S.A.'s trademark registration success rate?

COGNIS FRANCE S.A. has a 40% trademark registration rate, with 8 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.